A61K 35/30
Nerves
Official title: Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
A61K35/30 (Nerves) appears on 864 US grants and 1,813 published applications in this corpus.
Search patents in A61K- Granted patents
- 864
- Published applications
- 1,813
- Assignees
- 727
- Inventors
- 3,084
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 3 | 0 |
| 1987 | 4 | 0 |
| 1988 | 4 | 0 |
| 1989 | 1 | 0 |
| 1990 | 4 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 7 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 7 | 0 |
| 1998 | 13 | 0 |
| 1999 | 9 | 0 |
| 2000 | 8 | 0 |
| 2001 | 7 | 5 |
| 2002 | 6 | 15 |
| 2003 | 2 | 15 |
| 2004 | 3 | 19 |
| 2005 | 3 | 18 |
| 2006 | 8 | 27 |
| 2007 | 2 | 30 |
| 2008 | 5 | 26 |
| 2009 | 6 | 35 |
| 2010 | 17 | 37 |
| 2011 | 12 | 54 |
| 2012 | 19 | 51 |
| 2013 | 16 | 51 |
| 2014 | 34 | 65 |
| 2015 | 38 | 90 |
| 2016 | 48 | 127 |
| 2017 | 60 | 95 |
| 2018 | 64 | 111 |
| 2019 | 65 | 120 |
| 2020 | 52 | 101 |
| 2021 | 54 | 119 |
| 2022 | 56 | 137 |
| 2023 | 50 | 119 |
| 2024 | 46 | 136 |
| 2025 | 66 | 117 |
| 2026 | 50 | 93 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Induced pluripotent stem cell derived glial enriched progenitor cells for the treatment of white matter stroke6 Oct 2026US 12,751,976 B2The Regents of the University of California
- Composition for inducing direct cross differentiation of somatic cell into motor neuron, and method for using same6 Oct 2026US 12,753,385 B2Unist (Ulsan National Institute of Science and Technology)
- Methods of differentiating neural cells and related compositions and methods of use15 Sep 2026US 12,734,196 B2Aspen Neuroscience, Inc.
- Oligodendrocyte progenitor cell compositions25 Aug 2026US 12,716,054 B2Asterias Biotherapeutics, Inc.
- Delivery of nucleic acids, proteins and small molecules in vitreous vesicular bodies18 Aug 2026US 12,708,647 B2Cornell University
- Intra-striatal co-transplantation of autologous treg and mda cells in parkinson's disease cell therapy8 Oct 2026US 2026/0306543 A1The McLean Hospital Corporation
- Retinal pigment epithelium cell therapy8 Oct 2026US 2026/0306548 A1The Regents of the University of California
- Plasmin-induced internal limiting membrane digestion facilitates donor retinal ganglion cell transplantation8 Oct 2026US 2026/0306549 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Composition for cultivation of stem cells including substrate with controlled mechanical strength and use thereof8 Oct 2026US 2026/0308514 A1Ajou University Industry-Academic Cooperation Foundation
- Universal treatment of down syndrome1 Oct 2026US 2026/0294978 A1DEI Biopharma
Most cited
By later US patents
- Renewable neural implant device and method1,456US 5,554,148 ABrown University Research Foundation · 1996
- Central occluder semi-biological heart valve842US 4,612,011 A1986
- Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products448US 6,083,523 ABrown University · 2000
- In vivo delivery of neurotransmitters by implanted, encapsulated cells398US 4,892,538 ABrown University Research Foundation · 1990
- In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny316US 5,750,376 ANeurospheres Holdings Ltd. · 1998